Nath Bio-Genes (India) Past Earnings Performance
Past criteria checks 3/6
Nath Bio-Genes (India)'s earnings have been declining at an average annual rate of -18.5%, while the Food industry saw earnings growing at 14.1% annually. Revenues have been growing at an average rate of 3.2% per year. Nath Bio-Genes (India)'s return on equity is 6.5%, and it has net margins of 11.7%.
Key information
-18.5%
Earnings growth rate
-18.5%
EPS growth rate
Food Industry Growth | 17.6% |
Revenue growth rate | 3.2% |
Return on equity | 6.5% |
Net Margin | 11.7% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Here's Why Shareholders Should Examine Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) CEO Compensation Package More Closely
Aug 11Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Solid Earnings May Rest On Weak Foundations
Jul 31Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Shares Fly 34% But Investors Aren't Buying For Growth
Jul 02These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Jun 27Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has More To Do To Multiply In Value Going Forward
Apr 05Returns On Capital At Nath Bio-Genes (India) (NSE:NATHBIOGEN) Have Hit The Brakes
Oct 24Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly
Aug 05Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has Some Way To Go To Become A Multi-Bagger
Jun 07Some Investors May Be Worried About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Feb 11We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt
Aug 27Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital Not Reflecting Well On The Business
Jun 19Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet
Feb 24Returns On Capital Signal Tricky Times Ahead For Nath Bio-Genes (India) (NSE:NATHBIOGEN)
May 27Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?
Feb 28The Trends At Nath Bio-Genes (India) (NSE:NATHBIOGEN) That You Should Know About
Feb 07Declining Stock and Decent Financials: Is The Market Wrong About Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)?
Jan 19The Nath Bio-Genes (India) (NSE:NATHBIOGEN) Share Price Is Up 149% And Shareholders Are Boasting About It
Jan 01Why Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay Matters
Dec 14These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Nov 26Here's What To Make Of Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Nov 05Do Its Financials Have Any Role To Play In Driving Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) Stock Up Recently?
Oct 15Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Might Not Be As Mispriced As It Looks After Plunging 25%
Sep 24Many Still Looking Away From Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
Sep 08Introducing Nath Bio-Genes (India) (NSE:NATHBIOGEN), The Stock That Soared 311% In The Last Five Years
Sep 07Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Doing What It Can To Lift Shares
Aug 18Here's What We Think About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay
Jul 26Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) Likely To Turn Things Around?
Jul 09Revenue & Expenses Breakdown
How Nath Bio-Genes (India) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 3,414 | 398 | 509 | 0 |
31 Mar 24 | 3,328 | 396 | 442 | 0 |
31 Dec 23 | 3,346 | 374 | 440 | 0 |
30 Sep 23 | 3,281 | 379 | 425 | 0 |
30 Jun 23 | 3,273 | 374 | 421 | 0 |
31 Mar 23 | 3,014 | 350 | 372 | 0 |
31 Dec 22 | 2,836 | -827 | 567 | 0 |
30 Sep 22 | 2,799 | -813 | 589 | 0 |
30 Jun 22 | 2,731 | -815 | 511 | 0 |
31 Mar 22 | 2,784 | -674 | 382 | 0 |
31 Dec 21 | 3,062 | 561 | 325 | 0 |
30 Sep 21 | 3,205 | 575 | 373 | 0 |
30 Jun 21 | 3,289 | 593 | 412 | 0 |
31 Mar 21 | 3,076 | 557 | 411 | 0 |
31 Dec 20 | 3,127 | 562 | 439 | 0 |
30 Sep 20 | 3,097 | 558 | 424 | 0 |
30 Jun 20 | 3,078 | 565 | 425 | 0 |
31 Mar 20 | 2,799 | 505 | 354 | 0 |
31 Dec 19 | 2,721 | 482 | 437 | 0 |
30 Sep 19 | 2,669 | 478 | 407 | 0 |
30 Jun 19 | 2,693 | 477 | 412 | 0 |
31 Mar 19 | 2,309 | 384 | 302 | 0 |
31 Dec 18 | 2,286 | 349 | 456 | 0 |
30 Sep 18 | 2,265 | 353 | 428 | 0 |
30 Jun 18 | 2,171 | 353 | 570 | 0 |
31 Mar 18 | 1,917 | 294 | 215 | 0 |
31 Dec 17 | 1,929 | 255 | 214 | 0 |
30 Sep 17 | 1,854 | 227 | 188 | 0 |
30 Jun 17 | 1,869 | 199 | 491 | 0 |
31 Mar 17 | 1,699 | 163 | 241 | 0 |
31 Dec 16 | 1,477 | 149 | 144 | 0 |
30 Sep 16 | 1,529 | 143 | 171 | 0 |
30 Jun 16 | 1,524 | 66 | 276 | 0 |
31 Mar 16 | 1,626 | 142 | 264 | 0 |
31 Dec 15 | 1,437 | -137 | 855 | 122 |
30 Sep 15 | 1,468 | 114 | 870 | 122 |
30 Jun 15 | 1,729 | 192 | 886 | 122 |
31 Mar 15 | 1,857 | 254 | 299 | 0 |
31 Mar 14 | 1,725 | 243 | 752 | 106 |
Quality Earnings: NATHBIOGEN has high quality earnings.
Growing Profit Margin: NATHBIOGEN's current net profit margins (11.7%) are higher than last year (11.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NATHBIOGEN's earnings have declined by 18.5% per year over the past 5 years.
Accelerating Growth: NATHBIOGEN's earnings growth over the past year (6.3%) exceeds its 5-year average (-18.5% per year).
Earnings vs Industry: NATHBIOGEN earnings growth over the past year (6.3%) did not outperform the Food industry 15%.
Return on Equity
High ROE: NATHBIOGEN's Return on Equity (6.5%) is considered low.